semaglutide compound ending The Shortage Is Ending: What's Next For Compounded Drugs? 🚨 FDA Moves to Permanently

Discover the Benefits of Semaglutide GLP-1 for Medical Weight Loss Semaglutide GLP-1 is a groundbreaking treatment for medical weight loss, helping individuals achieve lasting results by improving insulin sensitivity and reducing appetite

The dysfunction may not be the same from patient to patient

- - - A new 2-year comparative study from NYU Langone just droppedand the results are clear: Bariatric Surgery vs GLP-1s (semaglutide/tirzepatide): 25.7% total body weight loss with surgery vs 5.3% with GLP-1s (intention-to-treat) Even in per-protocol analysis (continuous GLP-1 use), surgery still outperformed: 24.6% vs 7.6% Surgery had better HbA1c improvement, too Translational Insight: Yes, the relatively low weight loss in the medication group was partly due to therapy interruptions and discontinuation

Persistent nausea is worth flagging to your prescriber

Its like the icky, queasy feeling in your stomach

For comparison, trials of 2.4 milligrams of Wegovy injections showed up to 17.4 percent weight reduction